Investor
Fierce Biotech Summit
A premier biotechnology conference highlighting drug development trends, clinical trial design, and life science investment strategies.
- When
- September, Late September
- Where
- Boston, USA
- Format
- In person
- Organiser
- Questex
- Region
- North America
- Scale
- About 600 attendees
- Founded
- 2022
The briefing
The Fierce Biotech Summit is an annual event organized by Questex that examines the business and science of biotechnology. It covers the entire therapeutic pipeline, from early-stage drug discovery and preclinical research to clinical development and commercialization. The summit features discussions on biotech financing, initial public offerings, and pharmaceutical deal-making trends. For healthtech and life science investors, it is a vital venue to assess emerging biological platforms and executive talent.
What to expect
- Biotech venture funding and IPO market trends
- Advancements in cell and gene therapies
- Pharma-biotech licensing and M&A activities
- AI-driven drug discovery pipelines
Who is in the room
Biotechnology company executives, pharmaceutical business development leaders, venture capitalists, and clinical researchers attend.
Background
Launched by the editors of the prominent trade publication Fierce Biotech to bring their industry coverage to life. It has established itself as a key autumn meeting for biotech executives on the East Coast.
Related events
Running this event, or spotted something out of date?